Monoclonal antibodies that neutralize HEV recognize an antigenic site at the carboxyterminus of an ORF2 protein vaccine.
about
Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structureEmerging and re-emerging swine virusesMutations within potential glycosylation sites in the capsid protein of hepatitis E virus prevent the formation of infectious virus particles.A Comprehensive Study of Neutralizing Antigenic Sites on the Hepatitis E Virus (HEV) Capsid by Constructing, Clustering, and Characterizing a Tool Box.Severe acute respiratory syndrome (SARS): development of diagnostics and antivirals.Application of truncated immunodominant polypeptide from hepatitis E virus (HEV) ORF2 in an assay to exclude nonspecific binding in detecting anti-HEV immunoglobulin MHepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation.Hepatitis E virus ORF2 protein activates the pro-apoptotic gene CHOP and anti-apoptotic heat shock proteinsStructure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathwayHepatitis E: an overview and recent advances in vaccine research.A single amino acid substitution changes antigenicity of ORF2-encoded proteins of hepatitis E virusSpatial configuration of hepatitis E virus antigenic domain.ORF3 protein of hepatitis E virus is not required for replication, virion assembly, or infection of hepatoma cells in vitro.Phage-displayed peptides that mimic epitopes of hepatitis E virus capsid.Dynamics of 8G12 competitive antibody in "prime-boost" vaccination of Hepatitis E vaccine.Positive reactions on Western blots do not necessarily indicate the epitopes on antigens are continuous.
P2860
Q27646563-2E5DC4C1-41B6-4E2B-9E66-FC4207612149Q28256924-56A9E49A-B23B-40D8-9F07-FE78113E5866Q30366046-5C943317-F4AA-4DC1-8CDC-989FC87A3A3AQ30375781-6C593CA4-B803-4C03-AB8A-244ACA283CF9Q33248093-0A469FA7-17AF-43B1-A857-5D479C2AC6CCQ33704689-5EAD1F4F-0274-4CAE-8C41-866CB54D9F15Q33769640-2D5B8450-7816-4237-9D31-8A98FC05CB25Q34038276-14C44DF1-AEE6-4ED1-956B-0CF8130D2BFBQ34236742-EDCE98F8-8503-486A-B88F-FB3388063162Q34334086-91BF098F-152F-4813-B895-6EB2363E4B3BQ34377883-A49B4954-FD9F-4EE4-B765-18E10394C1D8Q34485189-6D3785B9-3B33-4D00-A42B-F5CDF545D17EQ35139263-D6F7A95F-2330-47FE-8294-FB741BF973D4Q40231413-8157A72A-E6A0-471C-99C7-19EB767E17F3Q40302625-B1EDBEC9-6954-4D59-908D-DB64434162F9Q45201742-FCB849AC-4E3F-4286-A4E7-049F6622B695
P2860
Monoclonal antibodies that neutralize HEV recognize an antigenic site at the carboxyterminus of an ORF2 protein vaccine.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Monoclonal antibodies that neu ...... us of an ORF2 protein vaccine.
@ast
Monoclonal antibodies that neu ...... us of an ORF2 protein vaccine.
@en
type
label
Monoclonal antibodies that neu ...... us of an ORF2 protein vaccine.
@ast
Monoclonal antibodies that neu ...... us of an ORF2 protein vaccine.
@en
prefLabel
Monoclonal antibodies that neu ...... us of an ORF2 protein vaccine.
@ast
Monoclonal antibodies that neu ...... us of an ORF2 protein vaccine.
@en
P2093
P1433
P1476
Monoclonal antibodies that neu ...... us of an ORF2 protein vaccine.
@en
P2093
Darren J Schofield
Hanh T Nguyen
Robert H Purcell
Suzanne U Emerson
P304
P356
10.1016/J.VACCINE.2003.07.008
P407
P577
2003-12-01T00:00:00Z